Brain Tumor Epidemiology Facts

New cases of Brain Tumors in the United States

Overall frequency of brain tumors: There were 97,944 brain tumors diagnosed per year on average from 2018-2022, or approximately 26 cases per 100,000 people that live in the US. Of these, 26% were malignant (25,773 cases) and #% were non-malignant, or approximately 7 malignant and 19 non-malignant cases per 100,000 people that live in the US. (Source: CBTRUS Report 2025)

Differences in brain tumor frequency by sex: More brain tumors are diagnosed in women (approximately 30 per 100,000 women in the US) as compared to men (approximately 22 per 100,000 men that live in the US). (Source: CBTRUS Report 2025)

Differences in brain tumor frequency by race/ethnicity: The highest frequency of new brain tumor diagnoses were in individuals who are non-Hispanic Black, where 11,672 cases are diagnosed per year on average (approximately 27 new cases per 100,000 people). The second highest frequency of new brain and other CNS tumor diagnoses is in individuals who are non-Hispanic White, where 67,509 cases are diagnosed per year on average (approximately 26 new cases per 100,000 people), followed by individuals who are Hispanic and any race (12,473 cases per year, and approximately 25 new cases per 100,000 people), non-Hispanic American Indian/Alaska Native (655 cases per year, and approximately 24 case per 100,000 people), and non-Hispanic Asian or Pacific Islander (4,516 cases per year, and approximately 20 cases per 100,000 people). (Source: CBTRUS Report 2025)

Prevalence

The overall number of people living with a brain or other CNS tumor (also known as ‘prevalence‘) at the end of 2019 for was estimated to be 1,323,121 cases, of which 14% were malignant (195,048 cases). (Source: Neff, et al. 2023.)

Incidence of brain tumors globally

New cases of malignant brain tumors globally: It is estimated that 321,731 new cases of primary malignant brain and other CNS tumors were diagnosed in the world in 2022. This represents 3.5 new cases per 100,000 people. These tumors were diagnosed more commonly in men (173,699 total cases, or approximately 4 per 100,000 men globally) than women (148,032 total cases, or approximately 3 per 100,000 women globally).(Source: GLOBOCAN).

Deaths due to primary brain tumors

On average, there are 17,637 deaths due to primary brain tumors in the United States every year, or approximately 4 deaths per 100,000 people in the US. This represents an average of 48 deaths per day (Source: CBTRUS Report 2025.)

Years of life lost prematurely due to primary brain Tumors

In 2018, a total of 379,695 years of expected life were lost due to early death attributed to brain and other CNS tumors. On average, each death due to malignant tumors resulted in 21.2 lost years of expected life (96% of all deaths), while deaths due to non-malignant tumors result in a mean YLL of 14.2 (Source: Gerstl, et al. 2025).

For more information see CBTRUS tumor type specific factsheets and the following publications and resources:

  • Price M, Ballard C, Benedetti J, Kruchko C, Barnholtz-Sloan JS, Ostrom QT. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2018-2022. Neuro Oncol. 2025. doi: 10.1093/neuonc/noaf194
  • Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024 Apr 4. doi: 10.3322/caac.21834.
  • The Global Cancer Observatory’s Cancer Today
  • SEER Explorer
  • Gerstl JVE, Price M, Bernstock JD, Kruchko C, Spanehl L, Karandikar PV, Barnholtz-Sloan JS, Smith TR, Claus EB, Ostrom QT. Years of life lost due to central nervous system tumor subtypes in the United States. Neuro Oncol. 2025 Jun 15:noaf142. doi: 10.1093/neuonc/noaf142.
  • Neff C, Price M, Cioffi G, Kruchko C, Waite KA, Barnholtz-Sloan JS, Ostrom QT. Complete prevalence of primary malignant and nonmalignant brain tumors in comparison to other cancers in the United States. Cancer. 2023;129(16):2514–21. Epub 20230518. doi: 10.1002/cncr.34837.